ÊÝËØ/ÒÅ´«Ñ§,Leptin/geneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÚÐIJ¡,coronary heart diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʵÑéÑо¿,experimental studyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ΣÏÕÒòËØ,Risk factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ͳ¼Æ·ÖÎö,statistical analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔÐ£ËÀ,acute myocardial infarctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©ÎïÁÆ·¨,Drug therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò»Ñõ»¯µªºÏø,nitric oxide synthaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²Ó¦ÓÃ,Clinical applicationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆÀ¼ÛÖ¸±ê,evaluation indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅÁ½ðɲ¡,Parkinson's diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²·ÖÎö,clinical analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÆËã»ú¿ØÖÆ,Computer ControlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²¹Û²ì,Clinical observationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ï¥¹Ø½Ú,knee jointÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö»µËÀÒò×Ó-¦Á,tumor necrosis factor-¦ÁÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñü×µ,Lumbar vertebraeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾¸Éϸ°û,neural stem cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÐÔ³Õ´ô,Vascular dementiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔ¹£Èû,Cerebral infarctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔÄÔ¹£ËÀ,Acute cerebral infarctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±íƤÉú³¤Òò×Ó,epidermal growth factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àà·çʪÐԹؽÚÑ×,rheumatoid arthritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÀÖÎ,controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à·¢ÐÔÓ²»¯,multiple sclerosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±×µ²¡,Cervical spondylosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔÐÔ̱»¾,cerebral palsyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÛÊöÎÄÏ×,review literatureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±äÓ¦ÐÔ±ÇÑ×,allergic rhinitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔǰÁÐÏÙÑ×,Chronic prostatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¦ÄÜÐÔÏû»¯²»Á¼,Functional dyspepsiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁòËáþ,magnesium sulfateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Èý²æÉñ¾Í´,trigeminal neuralgiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²ÊÔÑé,clinical trialÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡×ã,diabetic footÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔöÉúÐÔñ£ºÛ,Hypertrophic scarÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´´ÃæÓúºÏ,Wound healingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õë´ÌÁÆ·¨,Acupuncture therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔθÑ×,chronic gastritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú»îÖÊÁ¿,quality of lifeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
÷ŹؽÚ,hip jointÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡¶¾ÐÔ¸ÎÑ×,Viral hepatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó¦ÓÃÑо¿,application researchÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÛѹ,intraocular pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²ÁÆÐ§,clinical effectÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔ×èÈûÐԷβ¡,chronic obstructive pulmonary diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ø×´ðåÕî,Herpes zosterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²ÎÂó×¢ÉäÒº,Shenmai injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ê×¼Ìåϵ,standard systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾ÖÔîÐÔÄÔȱѪ,focal cerebral ischemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉË¿ÚÓúºÏ,wound healingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôм¤ËØÊÜÌå,progesterone receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç´Ì¼¤,Electrical stimulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
NKϸ°û,NK cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Î¸½×¢ÉäÒº,Shenfu injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ô¼ÁÐԹؽÚÑ×,adjuvant arthritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TÁܰÍϸ°ûÑÇȺ,T-lymphocyte subsetsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´Á÷ÐÔʳ¹ÜÑ×,Reflux esophagitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔÖ§Æø¹ÜÑ×,Chronic bronchitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç×Ó±Ç,Electronic noseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÐÑõÔ˶¯,aerobic exerciseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔË®Ö×,Brain edemaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÄÒÂѳ²×ÛºÏÕ÷,Polycystic ovary syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õï¶ÏÏÔÏñ,diagnostic imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×µ¶¯Âö,Vertebral arteryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔçÆÚ¸ÉÔ¤,early interventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÂ黯¼î,Ephedrine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÄÀíÒòËØ,psychological factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬¾±ÃÓÀÃ,Cervical erosionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹Ü»îÐÔ³¦ëÄ,Vasoactive Intestinal PeptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Èå¼ÒÎÄ»¯,Confucian cultureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θð¤Ä¤,gastric mucosaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐéÄâÈË,Virtual humanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θʳ¹Ü·´Á÷,gastroesophageal refluxÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔ¸ßѪѹ,essential hypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´óÄÔÖж¯Âö,Middle cerebral arteryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔήËõÐÔθÑ×,chronic atrophic gastritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔȱѪÔÙ¹à×¢,Cerebral ischemia-reperfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¹ËèÐ;±×µ²¡,Cervical spondylotic myelopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔÝ¡ÂéÕî,chronic urticariaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÀÒ°±ËáôÇ»¯Ã¸,tyrosine hydroxylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²¾Ñé,clinical experienceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θճĤ,gastric mucosaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ù´¡ÀíÂÛ,basic theoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÌÉ«Ïû·Ñ,green consumptionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Í·Õë,scalp acupunctureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÖÉ¢ÕÅÁ¿³ÉÏñ,Diffusion tensor imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´´ÉËÐÔÄÔËðÉË,Traumatic brain injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔȱÑõ,Cerebral anoxiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤Éú³¤Òò×ÓÀà,Vascular endothelial growth factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äæ×ªÂ¼¾ÛºÏøÁ´·´Ó¦,Reverse transcriptase polymerase chain reactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
֪ʶ±í´ï,knowledge representationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔçÆÚ¿µ¸´,Early rehabilitationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÖÊõÆÚ¼ä,Intraoperative periodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆÀ¼Û·½·¨,evaluation methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ÌÔÝÐÔÄÔȱѪ·¢×÷,Transient ischemic attackÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔµ¨ÄÒÑ×,Acute cholecystitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪÁ÷ËÙ¶È,Blood flow velocityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êõºó²¢·¢Ö¢,postoperative complicationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾×èÖÍ,Nerve blockÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|